FDA Inspection 1338886 — ImpactLife
The FDA completed an inspection of ImpactLife on Sep 28, 2026 in Coralville, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 28, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Coralville, IA (United States)